T

T Man Pharmaceutical PCL
SET:TMAN

Watchlist Manager
T Man Pharmaceutical PCL
SET:TMAN
Watchlist
Price: 10.3 THB 0.98% Market Closed
Market Cap: 4.1B THB

T Man Pharmaceutical PCL
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

T Man Pharmaceutical PCL
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
T
T Man Pharmaceutical PCL
SET:TMAN
Operating Income
฿546.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mega Lifesciences PCL
SET:MEGA
Operating Income
฿3B
CAGR 3-Years
6%
CAGR 5-Years
14%
CAGR 10-Years
16%
I
Inter Pharma PCL
SET:IP
Operating Income
฿125m
CAGR 3-Years
-8%
CAGR 5-Years
9%
CAGR 10-Years
N/A
J
Jack Chia Industries Thailand PCL
SET:JCT
Operating Income
฿146.3m
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
4%
J
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
Operating Income
฿105m
CAGR 3-Years
30%
CAGR 5-Years
22%
CAGR 10-Years
N/A
B
Bangkok Lab and Cosmetic PCL
SET:BLC
Operating Income
฿230.5m
CAGR 3-Years
37%
CAGR 5-Years
45%
CAGR 10-Years
N/A
No Stocks Found

T Man Pharmaceutical PCL
Glance View

Market Cap
4.1B THB
Industry
N/A

T Man Pharmaceutical PCL is a TH-based company operating in industry. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2024-10-22. T.Man Pharmaceutical Public Company Limited is engaged in purchasing, importing, manufacturing, original equipment manufacturing, distributing and exporting of modern medicines, traditional medicine, dietary supplements, and health care products for the healthcare industry with subsidiaries as manufacturers. Its segments include manufactured products under own brand, manufactured products under third parties’ brand and trading products. With a diverse range of manufacturing machinery, it can produce various types of pharmaceutical products, meeting the needs of every consumer. Its production capabilities include tablets, capsules, powders, liquids, and semisolids. The company offers capsule products, including both hard and soft capsules in various sizes, all made with imported, high-quality raw materials. Its product range covers a wide range of diseases and comes in various forms, including uncoated tablets, sugar-coated tablets, film-coated tablets, enteric-coated tablets, and suppositories.

TMAN Intrinsic Value
16.11 THB
Undervaluation 36%
Intrinsic Value
Price
T

See Also

What is T Man Pharmaceutical PCL's Operating Income?
Operating Income
546.7m THB

Based on the financial report for Dec 31, 2024, T Man Pharmaceutical PCL's Operating Income amounts to 546.7m THB.

What is T Man Pharmaceutical PCL's Operating Income growth rate?
Operating Income CAGR 1Y
14%

Over the last year, the Operating Income growth was 14%.

Back to Top